Confusion and Severe Hyponatremia in an Older Adult on Two New Medications
A 72-year-old woman is brought to the emergency department by her daughter with 3 days of worsening confusion and unsteadiness. She began sertraline 50 mg daily 6 weeks ago for depression and hydrochlorothiazide 25 mg daily 3 weeks ago for hypertension. She is afebrile; BP 128/74 mmHg, pulse 76/min, weight stable at 61 kg. There is no edema, mucous membranes are moist, and jugular venous pressure is normal. She is alert but disoriented to time and place; there has been no seizure activity. Labs: serum sodium 116 mmol/L, serum osmolality 250 mOsm/kg, urine osmolality 480 mOsm/kg, urine sodium 62 mmol/L, random glucose 6.1 mmol/L, TSH normal, creatinine 78 micromol/L. Serum potassium and bicarbonate are normal.
1. Using the volume status and urine studies, explain the mechanism of this patient's hyponatremia and explain why the findings are not consistent with diuretic-induced volume depletion.
Read the worked answer
- Serum values confirm true hypotonic hyponatremia: Na 116 mmol/L with measured osmolality 250 mOsm/kg rules out pseudohyponatremia (normal osmolality) and hyperglycemic dilution (glucose is only 6.1 mmol/L).
- Urine studies point to impaired free-water excretion, not salt loss: urine osmolality 480 mOsm/kg is far above the ~100 mOsm/kg expected with appropriate ADH suppression, and urine Na 62 mmol/L shows the kidney is still wasting sodium despite a low serum sodium.
- Clinical assessment is euvolemic: no orthostasis, normal JVP, moist mucosae, no edema. Volume depletion from a thiazide would typically show low urine sodium (<30 mmol/L after diuretic effect wears off), tachycardia, or postural symptoms; here the urine sodium is high with a euvolemic exam.
- Most likely diagnosis: SIADH, drug-associated. Sertraline is a well-recognized cause of SIADH, and thiazides cause hyponatremia through reduced diluting capacity plus ADH stimulation and are a classic precipitant when combined with an SSRI. Both drugs were started recently, which fits the timeline.
- Before finalizing: confirm serum osmolality, TSH, and cortisol are normal (TSH is normal here) and review for other causes (pain, nausea, pneumonia, CNS pathology, other medications such as PPIs, carbamazepine, or NSAIDs).
2. Describe how fast the sodium should be corrected, when hypertonic saline is indicated, and the main iatrogenic complication to avoid.
Read the worked answer
- Rate limit first: this is chronic hyponatremia (onset over days to weeks), so the correction should not exceed 8 mmol/L in 24 hours (some guidelines allow up to 10) regardless of which fluid is used, to avoid osmotic demyelination syndrome (ODS). Risk factors for ODS that apply here include age, female sex, and baseline Na <120 mmol/L.
- Is hypertonic saline indicated? 3% NaCl (typically a 100–150 mL bolus over 20 minutes, may repeat) is reserved for severe symptoms - seizures, obtundation, coma, respiratory distress. This patient is confused but awake and protecting her airway, so symptomatic treatment with fluid restriction and drug withdrawal is appropriate unless she deteriorates. Confusion alone is a borderline indication; reassess frequently.
- Avoid the classic error: giving isotonic (0.9%) saline to a patient with SIADH can worsen hyponatremia, because the kidney excretes the salt and retains the water. If isotonic fluid is given for any reason, monitor sodium every 4–6 hours.
- If the sodium rises too fast: stop the stimulus (fluid restriction, hypertonic saline), and consider D5W plus desmopressin to re-lower the sodium and "clamp" the rate of rise.
- Monitoring plan: serum sodium every 4–6 hours initially, strict fluid balance, daily weights, and neurological checks for signs of ODS (dysarthria, dysphagia, quadriparesis, behavioural change) appearing 2–6 days later.
3. List the medication changes you would recommend and the counselling/monitoring points for the prescriber.
Read the worked answer
- Stop hydrochlorothiazide now. Hyponatremia is a dose- and time-related thiazide effect and it is the most modifiable contributor. Suggest an alternative antihypertensive - for example amlodipine or a low-dose ACE inhibitor/ARB - with renal function and potassium checked 1–2 weeks after starting an ACE inhibitor/ARB.
- Do not simply stop sertraline without a plan. Abrupt discontinuation risks discontinuation syndrome and relapse of depression. The safest course is to hold or reduce it while the patient is acutely symptomatic, then discuss with the prescriber whether to restart at a lower dose, switch to an agent with lower SIADH risk (e.g., mirtazapine or bupropion), or continue with sodium monitoring if it is the only effective option. Document this as a shared decision.
- Audit the rest of the list: NSAIDs, PPIs, carbamazepine, and desmopressin all worsen hyponatremia and should be avoided or minimized.
- Counsel the patient and daughter: fluid restriction to roughly 1–1.5 L/day if advised, no "drinking to thirst" during this period, recognize early symptoms (headache, nausea, confusion, unsteadiness), and seek care early for vomiting or diarrhea, which can acutely worsen sodium.
- Follow-up: recheck sodium within 3–7 days of discharge and again after 2–4 weeks and after any dose change. If a thiazide is ever restarted, check sodium at 1 and 4 weeks.